"10.1371_journal.pone.0019042","plos one","2011-04-27T00:00:00Z","José M Molina-Guijarro; Álvaro Macías; Carolina García; Eva Muñoz; Luis F García-Fernández; Miren David; Lucía Núñez; Juan F Martínez-Leal; Victoria Moneo; Carmen Cuevas; M Pilar Lillo; Carlos Villalobos Jorge; Carmen Valenzuela; Carlos M Galmarini","Departamento de Biología Celular, PharmaMar S.A., Colmenar Viejo, Madrid, Spain; Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain; Departamento Biofísica, Instituto de Química-Física Rocasolano (CSIC), Madrid, Spain; Instituto de Biología y Genética Molecular (CSIC-UVA), Valladolid, Spain","Conceived and designed the experiments: CC MPL CV CVJ CMG. Performed the experiments: JMMG AM CG EM LFGF MD LN JFML VM. Analyzed the data: JMMG AM CG EM LFGF MD LN JFML VM CC MPL CV CVJ CMG. Contributed reagents/materials/analysis tools: JMMG AM CG EM LFGF MD LN JFML VM CC MPL CV CVJ CMG. Wrote the paper: JMMG AM CG EM LFGF MD LN JFML VM CC MPL CV CVJ CMG.","José M Molina-Guijarro, Luis Francisco García-Fernández, Juan Fernando Martínez-Leal, Victoria Moneo, Carmen Cuevas and Carlos M. Galmarini are employees and shareholders of PharmaMar S.A. Actual patent application of Irvalec belongs to PharmaMar S.A. There are no products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","04","José M Molina-Guijarro","JMMG",14,TRUE,5,9,14,14,TRUE,TRUE,TRUE,1,"2",FALSE
